Subthalamic Nucleus, Akinesia and Parkinson's Disease
Recruiting now · Not applicable
Conditions studied: Parkinson's Disease
In brief
This program aims to understand the role of the subthalamic nucleus in the control of the movement in healthy humans and patients with Parkinson's disease, how the STN dysfunction contributes to akinesia and how the STN stimulation improves motor signs in PD patients .
Key facts
- Study ID
- NCT01682668
- Run by
- Institut National de la Santé Et de la Recherche Médicale, France
- People needed
- 180
- Starts
- 2013-02-01
- Expected to finish
- 2026-08-01
- Last updated by the study team
- 2026-07-07
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.
Where it is running
- Groupe Hospitalier Pitie-Salpêtrière — Paris, PARIS, France (enrolling)
- CIC-GHPS — Paris, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.